文献速递精神分裂症与精神病性障碍

首发精神病患者抗精神病药治疗与未治疗的功能连接研究

Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该研究为三盲随机临床试验的二次分析,纳入59例首发精神病患者(28例接受第二代抗精神病药+心理社会治疗,31例接受安慰剂+心理社会治疗)和27名健康对照,在基线、3个月和12个月进行静息态功能磁共振扫描。基线时患者表现出广泛功能连接减低,主要涉及默认模式网络和边缘系统;安慰剂组从基线到3个月这些系统的功能连接增加,且部分变化与临床结局改善相关;抗精神病药暴露则主要与丘脑和大脑其余区域之间的功能连接增加相关。

要点

  • 首发精神病患者基线存在广泛功能连接减低,主要累及默认模式网络和边缘系统。
  • 安慰剂联合心理社会治疗组早期出现默认模式网络和皮质边缘系统功能连接正常化。
  • 抗精神病药暴露与丘脑-皮层网络的功能连接变化相关。

核心结论

  • 首发精神病未用药患者基线存在广泛功能连接减低,安慰剂联合心理社会治疗组早期出现默认模式网络和皮质边缘系统功能连接正常化。
  • 抗精神病药暴露与功能连接变化集中在丘脑-皮层网络相关。

研究设计与样本

  • 该研究为三盲随机临床试验的二次分析,招募期2008年4月至2016年12月共5年。
  • 纳入59例首发精神病患者(抗精神病药+心理社会治疗28例,安慰剂+心理社会治疗31例)和27名健康对照。
  • 患者需低自杀和攻击风险、未治疗精神病病程小于6个月、居住稳定且有社会支持,两组均接受强化心理社会治疗。
  • 在基线、3个月和12个月完成静息态功能磁共振扫描,数据分析时间为2019年5月至2020年8月。

主要发现

  • 基线时患者相比对照存在广泛功能连接减低,主要影响默认模式网络、边缘系统与大脑其余区域的交互。
  • 从基线到3个月,安慰剂组功能连接增加主要位于相同系统,部分变化与临床结局改善相关(典型相关分析R=0.901;家庭wise误差校正P=.005)。
  • 抗精神病药暴露与功能连接增加主要位于丘脑与大脑其余区域之间相关。

关键数值与推荐

  • 主要结局包括基线时患者与对照的功能连接差异、用药与未用药患者基线至3个月的功能连接变化、纵向功能连接变化与临床结局的关联。
  • 附加目的是探究基线后12个月的长期功能连接变化,这些结局未预注册。

临床怎么用

  • 对于低自杀和攻击风险的首发精神病患者,心理社会干预联合安慰剂治疗早期可出现默认模式网络和皮质边缘系统功能连接正常化。
  • 抗精神病药治疗可能主要影响丘脑-皮层网络的功能连接,临床解读功能连接变化时需考虑用药状态。

局限性

  • 该研究为二次分析,主要结局未预注册。
  • 样本量较小(59例患者和27名对照),患者经过筛选(低自杀和攻击风险、未治疗病程短、居住稳定),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Altered functional connectivity (FC) is a common finding in resting-state functional magnetic resonance imaging (rs-fMRI) studies of people with psychosis, yet how FC disturbances evolve in the early stages of illness, and how antipsychotic treatment influences these disturbances, remains unknown. OBJECTIVE: To investigate longitudinal FC changes in antipsychotic-naive and antipsychotic-treated patients with first-episode psychosis (FEP). DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a triple-blind, randomized clinical trial was conducted over a 5-year recruitment period between April 2008 and December 2016 with 59 antipsychotic-naive patients with FEP receiving either a second-generation antipsychotic or a placebo pill over a treatment period of 6 months. Participants were required to have low suicidality and aggression, to have a duration of untreated psychosis of less than 6 months, and to be living in stable accommodations with social support. Both FEP groups received intensive psychosocial therapy. A healthy control group was also recruited. Participants completed rs-fMRI scans at baseline, 3 months, and 12 months. Data were analyzed from May 2019 to August 2020. INTERVENTIONS: Resting-state functional MRI was used to probe brain FC. Patients received either a second-generation antipsychotic or a matched placebo tablet. Both patient groups received a manualized psychosocial intervention. MAIN OUTCOMES AND MEASURES: The primary outcomes of this analysis were to investigate (1) FC differences between patients and controls at baseline; (2) FC changes in medicated and unmedicated patients between baseline and 3 months; and (3) associations between longitudinal FC changes and clinical outcomes. An additional aim was to investigate long-term FC changes at 12 months after baseline. These outcomes were not preregistered. RESULTS: Data were analyzed for 59 patients (antipsychotic medication plus psychosocial treatment: 28 [47.5%]; mean [SD] age, 19.5 [3.0] years; 15 men [53.6%]; placebo plus psychosocial treatment: 31 [52.5%]; mean [SD] age, 18.8 [2.7]; 16 men [51.6%]) and 27 control individuals (mean [SD] age, 21.9 [1.9] years). At baseline, patients showed widespread functional dysconnectivity compared with controls, with reductions predominantly affecting interactions between the default mode network, limbic systems, and the rest of the brain. From baseline to 3 months, patients receiving placebo showed increased FC principally within the same systems; some of these changes correlated with improved clinical outcomes (canonical correlation analysis R = 0.901; familywise error-corrected P = .005). Antipsychotic exposure was associated with increased FC primarily between the thalamus and the rest of the brain. CONCLUSIONS AND RELEVANCE: In this secondary analysis of a clinical trial, antipsychotic-naive patients with FEP showed widespread functional dysconnectivity at baseline, followed by an early normalization of default mode network and cortical limbic dysfunction in patients receiving placebo and psychosocial intervention. Antipsychotic exposure was associated with FC changes concentrated on thalamocortical networks. TRIAL REGISTRATION: ACTRN12607000608460.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chopra S, Francey SM, O'Donoghue B, et al. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry. 2021. PMID: 34160595. doi:10.1001/jamapsychiatry.2021.1422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。